In the literature, significantly lower concentrations of Hb were detected in patients with bladder cancer having bone metastasis, suggesting lower levels of Hb to be a risk factor for developing bone metastasis in newly diagnosed patients with bladder cancer.42 Here, GSTM1 is linked to urinary bladder cancer.